Study Details
Full Title
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS
WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)/METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS
WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)/METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
Principal Investigator
Amreen
Dinani
Protocol Number
PRO00117203
NCT ID
NCT06528314
Phase
III
Enrollment Status
Open to Enrollment